US Stroke Management Market Size Study, by Type (Diagnostics, Therapeutics, Software), by Application (Ischemic Stroke, Haemorrhagic Stroke) Forecasts 2022-2032
US Stroke Management Market is valued at approximately USD 10.55 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.87% over the forecast period 2024-2032. Care for strokes includes offering thorough treatment to those who have had a stroke, an abrupt blockage in blood flow to the brain. An obstruction in a blood vessel may cause an ischemic stroke, whereas a blood vessel rupturing can result in a hemorrhagic stroke. It is essential to use various medical interventions and therapies to effectively treat a stroke, prevent additional brain damage, reduce disability, and support the recovery process. Treatment plans include immediate actions such as clot-busting drugs or surgery, therapies such as physical therapy, speech therapy, and occupational therapy, medications to prevent future strokes, and lifestyle changes to lower risk factors such as high blood pressure, diabetes, and smoking. The goal of stroke management is to enhance results and the general well-being of individuals who have had a stroke. Major progress in the US Stroke Management Market includes the rise of telemedicine and digital health choices for remote stroke care, the utilization of artificial intelligence and machine learning for prompt detection and personalized treatment, and the emphasis on multidisciplinary stroke groups and comprehensive facilities to enhance coordination and intervention efficacy. These developments showcase innovation, effectiveness, and enhanced results for stroke patients.
Respective important factors are responsible for the expansion of the US Stroke Management Market. Progress in medical technology, such as telemedicine and digital health solutions, plays a vital role in offering remote evaluation and care for stroke patients, ultimately enhancing their access to specialized treatment. The increased utilization of artificial intelligence and machine learning algorithms in stroke care results in improved early detection and customized treatment plans, ultimately resulting in improved patient outcomes. Encouraging stroke teams with diverse skills and comprehensive stroke centres fosters collaboration among healthcare providers, leading to efficient interventions and improved patient outcomes. However, the market encounters specific limitations as well. The difficulties are centred on the regulations for telemedicine and digital health advancements, as well as worries about the privacy and security of data in AI-powered healthcare technologies. Furthermore, the expenses related to implementing advanced stroke management technologies and the requirement for qualified professionals present obstacles to the widespread acceptance and efficient utilization of these innovations in the US Stroke Management Market.
Major market player included in this report are:
Medical Device Business Services, Inc.
Biogen Inc.
Boston Scientific Corporation
Abbott Laboratories
Stryker Corporation
Penumbra Inc
Genentech, Inc.
NeuroLogica Corporation
Cardinal Health, Inc.
Medtronic plc
The detailed segments and sub-segments of the market are explained below:
By Type
Diagnostics
Therapeutics
Software
By Application
Ischemic Stroke
Haemorrhagic Stroke
Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market
Respective important factors are responsible for the expansion of the US Stroke Management Market. Progress in medical technology, such as telemedicine and digital health solutions, plays a vital role in offering remote evaluation and care for stroke patients, ultimately enhancing their access to specialized treatment. The increased utilization of artificial intelligence and machine learning algorithms in stroke care results in improved early detection and customized treatment plans, ultimately resulting in improved patient outcomes. Encouraging stroke teams with diverse skills and comprehensive stroke centres fosters collaboration among healthcare providers, leading to efficient interventions and improved patient outcomes. However, the market encounters specific limitations as well. The difficulties are centred on the regulations for telemedicine and digital health advancements, as well as worries about the privacy and security of data in AI-powered healthcare technologies. Furthermore, the expenses related to implementing advanced stroke management technologies and the requirement for qualified professionals present obstacles to the widespread acceptance and efficient utilization of these innovations in the US Stroke Management Market.
Major market player included in this report are:
Medical Device Business Services, Inc.
Biogen Inc.
Boston Scientific Corporation
Abbott Laboratories
Stryker Corporation
Penumbra Inc
Genentech, Inc.
NeuroLogica Corporation
Cardinal Health, Inc.
Medtronic plc
The detailed segments and sub-segments of the market are explained below:
By Type
Diagnostics
Therapeutics
Software
By Application
Ischemic Stroke
Haemorrhagic Stroke
Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market
CHAPTER 1. US STROKE MANAGEMENT MARKET DEFINITION AND RESEARCH ASSUMPTIONS
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
CHAPTER 2. EXECUTIVE SUMMARY
2.1. US Stroke Management Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Type
2.2.2. By Application
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
CHAPTER 3. US STROKE MANAGEMENT MARKET DYNAMICS
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
CHAPTER 4. US STROKE MANAGEMENT MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. US STROKE MANAGEMENT MARKET SIZE & FORECASTS BY TYPE 2022-2032
5.1. Diagnostics
5.2. Therapeutics
5.3. Software
CHAPTER 6. US STROKE MANAGEMENT MARKET SIZE & FORECASTS BY APPLICATION 2022-2032
6.1. Ischemic Stroke
6.2. Haemorrhagic Stroke
CHAPTER 7. COMPETITIVE INTELLIGENCE
7.1. Key Company SWOT Analysis
7.1.1. Company
7.1.2. Company
7.1.3. Company
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. Medical Device Business Services, Inc.
7.3.1.1. Key Information
7.3.1.2. Overview
7.3.1.3. Financial (Subject to Data Availability)
7.3.1.4. Product Summary
7.3.1.5. Market Strategies
7.3.2. Biogen Inc.
7.3.3. Boston Scientific Corporation
7.3.4. Abbott Laboratories
7.3.5. Stryker Corporation
7.3.6. Penumbra Inc
7.3.7. Genentech, Inc.
7.3.8. NeuroLogica Corporation
7.3.9. Cardinal Health, Inc.
7.3.10. Medtronic plc
CHAPTER 8. RESEARCH PROCESS
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
CHAPTER 2. EXECUTIVE SUMMARY
2.1. US Stroke Management Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Type
2.2.2. By Application
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
CHAPTER 3. US STROKE MANAGEMENT MARKET DYNAMICS
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
CHAPTER 4. US STROKE MANAGEMENT MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. US STROKE MANAGEMENT MARKET SIZE & FORECASTS BY TYPE 2022-2032
5.1. Diagnostics
5.2. Therapeutics
5.3. Software
CHAPTER 6. US STROKE MANAGEMENT MARKET SIZE & FORECASTS BY APPLICATION 2022-2032
6.1. Ischemic Stroke
6.2. Haemorrhagic Stroke
CHAPTER 7. COMPETITIVE INTELLIGENCE
7.1. Key Company SWOT Analysis
7.1.1. Company
7.1.2. Company
7.1.3. Company
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. Medical Device Business Services, Inc.
7.3.1.1. Key Information
7.3.1.2. Overview
7.3.1.3. Financial (Subject to Data Availability)
7.3.1.4. Product Summary
7.3.1.5. Market Strategies
7.3.2. Biogen Inc.
7.3.3. Boston Scientific Corporation
7.3.4. Abbott Laboratories
7.3.5. Stryker Corporation
7.3.6. Penumbra Inc
7.3.7. Genentech, Inc.
7.3.8. NeuroLogica Corporation
7.3.9. Cardinal Health, Inc.
7.3.10. Medtronic plc
CHAPTER 8. RESEARCH PROCESS
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
LIST OF TABLES
TABLE 1. US Stroke Management market, report scope
TABLE 2. US Stroke Management market estimates & forecasts by Type 2022-2032 (USD Billion)
TABLE 3. US Stroke Management market estimates & forecasts by Application 2022-2032 (USD Billion)
TABLE 4. US Stroke Management market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 5. US Stroke Management market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 6. US Stroke Management market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. US Stroke Management market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. US Stroke Management market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. U.S. Stroke Management market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. U.S. Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 11. U.S. Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 12. List of secondary sources, used in the study of US Stroke Management Market.
TABLE 13. List of primary sources, used in the study of US Stroke Management Market.
TABLE 14. Years considered for the study.
TABLE 15. Exchange rates considered
TABLE 1. US Stroke Management market, report scope
TABLE 2. US Stroke Management market estimates & forecasts by Type 2022-2032 (USD Billion)
TABLE 3. US Stroke Management market estimates & forecasts by Application 2022-2032 (USD Billion)
TABLE 4. US Stroke Management market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 5. US Stroke Management market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 6. US Stroke Management market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. US Stroke Management market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. US Stroke Management market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. U.S. Stroke Management market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. U.S. Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 11. U.S. Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 12. List of secondary sources, used in the study of US Stroke Management Market.
TABLE 13. List of primary sources, used in the study of US Stroke Management Market.
TABLE 14. Years considered for the study.
TABLE 15. Exchange rates considered
LIST OF FIGURES
FIG 1. US Stroke Management market, research methodology
FIG 2. US Stroke Management market, market estimation techniques
FIG 3. US market size estimates & forecast methods.
FIG 4. US Stroke Management market, key trends 2023
FIG 5. US Stroke Management market, growth prospects 2022-2032
FIG 6. US Stroke Management market, porters 5 force model
FIG 7. US Stroke Management market, pestel analysis
FIG 8. US Stroke Management market, value chain analysis
FIG 9. US Stroke Management market by segment, 2022 & 2032 (USD Billion)
FIG 10. US Stroke Management market by segment, 2022 & 2032 (USD Billion)
FIG 11. US Stroke Management market by segment, 2022 & 2032 (USD Billion)
FIG 12. US Stroke Management market by segment, 2022 & 2032 (USD Billion)
FIG 13. US Stroke Management market by segment, 2022 & 2032 (USD Billion)
FIG 14. US Stroke Management market, company market share analysis (2023)
FIG 1. US Stroke Management market, research methodology
FIG 2. US Stroke Management market, market estimation techniques
FIG 3. US market size estimates & forecast methods.
FIG 4. US Stroke Management market, key trends 2023
FIG 5. US Stroke Management market, growth prospects 2022-2032
FIG 6. US Stroke Management market, porters 5 force model
FIG 7. US Stroke Management market, pestel analysis
FIG 8. US Stroke Management market, value chain analysis
FIG 9. US Stroke Management market by segment, 2022 & 2032 (USD Billion)
FIG 10. US Stroke Management market by segment, 2022 & 2032 (USD Billion)
FIG 11. US Stroke Management market by segment, 2022 & 2032 (USD Billion)
FIG 12. US Stroke Management market by segment, 2022 & 2032 (USD Billion)
FIG 13. US Stroke Management market by segment, 2022 & 2032 (USD Billion)
FIG 14. US Stroke Management market, company market share analysis (2023)
